SYNA · Synaptics

The thesis

Synaptics' shares trade as a claim on onsemi's $123.00 per share cash offer, and that price caps the gain. The 17 November 2026 shareholder vote is the next fixed test. After it, antitrust filings in China, Hungary, Japan, South Korea and Taiwan, plus foreign-investment reviews in France and the United Kingdom, decide whether the deal closes by mid-2027. The shares are more likely to trail the S&P 500 over the next three months than to lead it.

The special meeting is set for 17 November 2026 at 9:00 a.m. Pacific Time under the definitive proxy dated 19 October 2026. Approval needs a majority of the 39,701,387 shares outstanding on the 13 October 2026 record date, so a share that does not vote counts as a vote against.

The shares closed at $117.86 on 11 November 2026, below the cash price. Six closes from 4 November to 11 November 2026 ran between $116.40 and $117.86. That range held through the first-quarter fiscal 2027 report of 5 November 2026, which came with no outlook and no call.

The only named rival, Cirrus Logic, said on 13 October 2026 that it is not pursuing a transaction. With the cash terms public since 1 October 2026 and no closing possible inside three months, the shares can earn only the slow narrowing of the gap to $123.00. The standing risk is a failed vote or a Chinese delay, which would widen it.

Bullish and bearish views on Synaptics Incorporated

The bull case on Synaptics Incorporated (SYNA), in brief: the vote date is fixed. The bear case: no rival bidder remains.

Bull case

• The vote date is fixed. The definitive proxy dated 19 October 2026 sets the special meeting for 17 November 2026. A yes vote leaves only regulatory conditions before closing. Synaptics DEFM14A, 19 October 2026
• Cash price with committed financing. The amended agreement of 1 October 2026 pays $123.00 per share in cash, about $5.7 billion in total. onsemi has a committed senior secured term loan of up to $2.45 billion from Morgan Stanley, and the deal has no financing condition. onsemi release, 1 October 2026
• onsemi pays if regulators block it. The merger proxy sets a $320 million fee that onsemi owes if required approvals fail. The fee gives onsemi a reason to offer remedies before it walks away.
• US antitrust review is done. The parties filed under the Hart-Scott-Rodino Act on 17 July 2026. The Federal Trade Commission granted early termination effective 12 August 2026, according to the proxy.
• Quarterly earnings held up. Synaptics reported first-quarter fiscal 2027 revenue of $294.0 million against $292.5 million a year earlier, and non-GAAP earnings of $1.26 per diluted share against $1.09 a year earlier, in its 8-K of 5 November 2026. Non-GAAP gross margin was 54.3%. Synaptics Q1 FY27 release, 5 November 2026

Bear case

• No rival bidder remains. Cirrus Logic's 8-K of 13 October 2026 confirmed it was "Party A" in the merger filings and said it is not currently pursuing a deal. Its proposals of $95.00 on 13 March 2026 and $102.50 on 1 April 2026 were both below $123.00, so no source of a higher price is visible.
• China's review looks demanding. ION Analytics' PaRR service reported lawyers expecting China's State Administration for Market Regulation (SAMR) to push the deal into a normal review instead of the simplified track. The Capitol Forum also expects rigorous scrutiny, citing both companies' sales to large Chinese customers. ION Analytics PaRR
• The timeline runs past three months. The companies still guide to a mid-2027 close. The outside date is 25 June 2027 and extends automatically in three-month steps to 25 March 2028 if only antitrust or foreign-investment conditions remain.
• Standalone results are softer than the prior quarter. First-quarter revenue of $294.0 million compares with $308.0 million in the June quarter. The chief executive cited supply constraints and memory-related demand effects, and smartphone softness in touch and wireless products. Cash fell to $367.7 million at 26 September 2026 from $442.5 million at 27 June 2026, with debt of $440.1 million current and $397.9 million long-term.
• The downside sits far below the deal price. The proxy shows a $73.87 close on 13 March 2026, before any bid became public. A broken deal would leave the shares trading on standalone value, well under $123.00.

Price setup

The shares closed at $117.86 on 11 November 2026. That is 21.0% below the 52-week intraday high of $149.11 set on 27 May 2026, under the original stock-for-stock terms, when Synaptics tracked onsemi's share price. The 52-week closing low was $58.52 on 20 November 2025.

The shares gained 9.8% over three months, from a $107.31 close on 13 August 2026. They sit above the 50-day average of $109.3 and the 200-day average of $104.0, both measured on adjusted closes through 11 November 2026.

Since the cash amendment, a pending cash deal sets the price, and the shares follow deal odds more than the chip sector. A fall toward the 50-day average would show the market pricing a real chance that the deal fails or slips.

SEC Form 4 filings show seven directors each received a grant of 1,782 shares on 2 November 2026. Chief executive Rahul Patel sold 4,302 shares at $117.55 on 20 October 2026 under a Rule 10b5-1 plan, filed 21 October 2026.

Catalysts ahead

• 17 November 2026: Special shareholder meeting to vote on the onsemi merger. Approval needs a majority of the 39,701,387 record-date shares; a yes vote leaves only regulatory conditions before closing.
• 25 June 2027: Initial outside date of the merger agreement. Extends automatically in three-month steps to 25 March 2028 if only antitrust or foreign-investment conditions remain; an extension would lengthen the wait for the $123.00 payment.

What would change the view

A daily close above $147.57, just under the 52-week intraday high of $149.11 (27 May 2026), which would show the shares leading the S&P 500. A disclosed rival proposal above $123.00 per share would show the same.

What it trades with

With cash consideration fixed at $123.00, Synaptics moves with deal odds and the time to closing more than with semiconductor indices or onsemi's share price. onsemi's results matter to the shares only if they change onsemi's commitment to the deal or its financing. The main shared exposure is US–China relations, because SAMR approval is the gating condition. Other pending chip mergers awaiting Chinese clearance would react to the same shift in Beijing's stance.